Reverse Iontophoresis for Noninvasive Glucose Monitoring: The Internal Standard Concept

Journal of Pharmaceutical Sciences

Volumn 92, Issue 11, 2003, Pages 2295-2302

  Sieg, Anke ^a,b   Guy, Richard H ^a,b   Delgado Charro, M Begoña ^a,b  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b Centre Interuniversitaire de Recherche et d'Enseignement   (France)

Author keywords

Electroosmosis; Iontophoresis; Noninvasive glucose monitoring; Skin; Transdermal

Indexed keywords

GLUCOSE; MANNITOL; SODIUM CHLORIDE; SODIUM ION;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CALIBRATION; CONCENTRATION RESPONSE; CONCEPT FORMATION; CONTROLLED STUDY; DIABETES MELLITUS; DOSE TIME EFFECT RELATION; EAR; ELECTROOSMOSIS; EVALUATION; EXTRACTION; GLUCOSE BLOOD LEVEL; IN VITRO STUDY; IONTOPHORESIS; METHODOLOGY; NON INVASIVE MEASUREMENT; NONHUMAN; PH MEASUREMENT; QUANTITATIVE ANALYSIS; REFERENCE VALUE; REVERSE ELECTROMIGRATION; REVERSE IONTOPHORESIS; SKIN CULTURE; SODIUM TRANSPORT; STANDARD; SWINE; TECHNOLOGY;

EID: 0242290402     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.10492     Document Type: Article

References (17)

1. The Diabetes Control and Complications Trial Research Group. 1993. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes-mellitus. N Engl J Med 329:977-986.
2. Koschinsky T, Heinemann L. 2001. Sensors for glucose monitoring: Technical and clinical aspects. Diabetes Metab Res Rev 17:113-123.
3. Sage BH. 1995. Iontophoresis. In: Smith EW, Maibach HI, editors. Percutaneous penetration enhancers. Boca Raton, FL: CRC Press, p 351-368.
4. Phipps JB, Gyory JR. 1992. Transdermal ion migration. Adv Drug Del Rev 9:137-176.
5. Burnette RR, Ongpipattanakul B. 1987. Characterization of the permselective properties of excised human skin during iontophoresis. J Pharm Sci 76:765-773.
6. Guy RH. 1998. Iontophoresis-Recent developments. J Pharm Pharmacol 50:371-374.
7. Rao G, Glikfeld P, Guy RH. 1993. Reverse iontophoresis: Developpement of a non-invasive approach for glucose monitoring. Pharm Res 10:1711-1715.
8. Rao G, Guy RH, Glikfeld P, LaCourse WR, Leung L, Tamada J, Potts RO, Azimi N. 1995. Reverse iontophoresis: Non-invasive glucose monitoring in vivo in humans. Pharm Res 12:1869-1873.
9. Tamada JA, Garg S, Jovanovic L, Pitzer KR, Fermi S, Potts RO. 1999. Noninvasive glucose monitoring-Comprehensive clinical results. JAMA 282:1839-1844.
10. Tamada JA, Bohannon NJV, Potts RO. 1995. Measurement of glucose in diabetics subjects using non-invasive transdermal extraction. Nat Med 1:1198-1201.
11. Tierney MJ, Tamada JA, Potts RO, Eastman RC, Pitzer KR, Ackerman NR, Fermi S. 2000. The GlucoWatch biographer: A frequent automatic and noninvasive glucose monitor. Ann Med 32:632-641.
12. Hillier TA, Abbott RD, Barrett EJ. 1999. Hyponatriaemia: Evaluating the correction factor for hyperglycemia. Am J Med 106:399-403.
13. Yoshida NH, Roberts MS. 1994. Role of conductivity in iontophoresis. 2. Anodal iontophoretic transport of phenylethylamine and sodium across excised human skin. J Pharm Sci 83:344-350.
14. Marro D, Guy RH, Delgado-Charro MB. 2001. Characterization of the iontophoretic permselectivity properties of human and pig skin. J Controlled Release 70:213-217.
15. Kim A, Green PG, Rao G, Guy RH. 1993. Convective solvent flow across the skin during iontophoresis. Pharm Res 10:1315-1320.
16. Santi P, Guy RH. 1996. Reverse iontophoresis-Parameters determining electroosmotic flow: I. pH and ionic strength. J Controlled Release 38:159-165.
17. Delgado-Charro MB, Guy RH. 2003. Transdermal reverse iontophoresis of valproate: A non-invasive method for therapeutic drug monitoring. Pharm Res 20:1508-1513.